What you should know:
1. Mr. Kenny will be responsible for leading the global spine implants, motion preservation, bone growth therapies and biologics businesses.
2. At Medtronic, Mr. Kenny oversaw 1,500 direct and nondirect sales personnel over a nine-year period.
3. Mr. Kenny most recently served as COO at Cardiovascular Systems, where he developed and commercialized new products worldwide.
4. He also held positions at Bausch and Lomb and B.Braun/McGaw.
More articles on devices:
Johnson & Johnson subsidiary launches product for surgical bleeding: 5 things to know
Stanford to acquire 2nd CyberKnife M6 system for neurosurgery
Andrews to expand with new clinical location — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
